Systane Clinical Experience Study

This study has been completed.
Information provided by (Responsible Party):
Alcon Research Identifier:
First received: January 7, 2009
Last updated: January 31, 2012
Last verified: January 2012
To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Condition Intervention Phase
Dry Eye Syndrome
Other: Systane
Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Study to Evaluate the Physical Effect of SYSTANE QID in People That Have Moderate to Severe Dry Feeling Eyes

Resource links provided by NLM:

Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • corneal and conjunctiva staining score [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Tear film break up time [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Enrollment: 941
Study Start Date: January 2009
Study Completion Date: October 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Systane
Systane ocular product
Other: Systane
Systane prescription


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • moderate to severe dry feeling eyes

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Alcon Research Identifier: NCT00818909     History of Changes
Other Study ID Numbers: CARES-3
Study First Received: January 7, 2009
Last Updated: January 31, 2012
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Alcon Research:
Dry eye
Moderate to severe dry eye

Additional relevant MeSH terms:
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Conjunctival Diseases
Corneal Diseases
Eye Diseases
Lacrimal Apparatus Diseases processed this record on November 30, 2015